Published in Nat Rev Clin Oncol on March 01, 2011
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature (2014) 2.84
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. Oncotarget (2012) 1.34
ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. Cell Death Differ (2014) 1.18
A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis. Eur J Pharmacol (2017) 1.12
Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex. ACS Chem Biol (2013) 1.12
The oncogene eIF4E: using biochemical insights to target cancer. J Interferon Cytokine Res (2013) 1.03
The cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cells. Biomed Res Int (2013) 0.95
Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species. Nat Prod Rep (2014) 0.95
A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma. Leukemia (2013) 0.95
Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail. Oncotarget (2014) 0.94
Ribosome-inactivating proteins: potent poisons and molecular tools. Virulence (2013) 0.94
Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. J Exp Clin Cancer Res (2012) 0.94
LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene (2014) 0.93
Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein. Oncogene (2012) 0.92
Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1. Cell Death Dis (2013) 0.92
Toward a genome-wide landscape of translational control. Cold Spring Harb Perspect Biol (2013) 0.92
New frontiers in translational control of the cancer genome. Nat Rev Cancer (2016) 0.92
The translational landscape of the splicing factor SRSF1 and its role in mitosis. Elife (2014) 0.89
Novel mechanism of MDA-7/IL-24 cancer-specific apoptosis through SARI induction. Cancer Res (2013) 0.89
Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma. Mol Cancer (2014) 0.89
Trespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culprits. Curr Opin Cell Biol (2012) 0.84
Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents. Bioorg Med Chem (2013) 0.84
The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M. BMC Cancer (2015) 0.83
Targeted cancer therapy: what if the driver is just a messenger? Cell Cycle (2011) 0.82
Active regulator of SIRT1 is required for ribosome biogenesis and function. Nucleic Acids Res (2013) 0.82
Eukaryotic Translation Initiation Factor 4E Is a Feed-Forward Translational Coactivator of Transforming Growth Factor β Early Protransforming Events in Breast Epithelial Cells. Mol Cell Biol (2015) 0.81
Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer. Trends Mol Med (2015) 0.80
New insights into 4E-BP1-regulated translation in cancer progression and metastasis. Cancer Cell Microenviron (2015) 0.79
Key contribution of eIF4H-mediated translational control in tumor promotion. Oncotarget (2015) 0.78
Growth factor signaling to mTORC1 by amino acid-laden macropinosomes. J Cell Biol (2015) 0.78
Phage display biopanning identifies the translation initiation and elongation factors (IF1α-3 and eIF-3) as components of Hsp70-peptide complexes in breast tumour cells. Cell Stress Chaperones (2011) 0.78
eIF4A1 is a promising new therapeutic target in ER-negative breast cancer. Cell Death Differ (2015) 0.77
Identification and Characterization of an eIF4e DNA Aptamer That Inhibits Proliferation With High Throughput Sequencing. Mol Ther Nucleic Acids (2014) 0.76
eIF4E is an important determinant of adhesion and pseudohyphal growth of the yeast S. cerevisiae. PLoS One (2012) 0.76
Revelations from a bicistronic calcium channel gene. Cell Cycle (2014) 0.76
Inflammatory conditions induce IRES-dependent translation of cyp24a1. PLoS One (2014) 0.76
Phosphoproteomics of colon cancer metastasis: comparative mass spectrometric analysis of the isogenic primary and metastatic cell lines SW480 and SW620. Anal Bioanal Chem (2016) 0.75
Improved eIF4E binding peptides by phage display guided design: plasticity of interacting surfaces yield collective effects. PLoS One (2012) 0.75
Cap-Independent Translation in Hematological Malignancies. Front Oncol (2015) 0.75
Therapeutic interventions to disrupt the protein synthetic machinery in melanoma. Pigment Cell Melanoma Res (2015) 0.75
Targeting translation initiation in breast cancer. Translation (Austin) (2014) 0.75
Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol (1961) 65.10
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell (2000) 17.44
eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem (1999) 14.59
The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol (2010) 11.19
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol (2009) 9.63
Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature (1994) 9.30
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature (1990) 7.74
4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev (1998) 6.89
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell (2005) 6.71
Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev (1990) 6.64
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene (2006) 6.54
Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell (1998) 6.47
Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov (2010) 6.07
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J (1996) 6.01
The pharmacology of mTOR inhibition. Sci Signal (2009) 5.36
A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J (1998) 5.18
4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell (2010) 4.48
Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell (2004) 4.34
Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol (2002) 4.11
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat Chem Biol (2006) 3.89
Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell (2010) 3.79
Recognition of polyadenylate RNA by the poly(A)-binding protein. Cell (1999) 3.76
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J (2006) 3.57
Dissecting eIF4E action in tumorigenesis. Genes Dev (2007) 3.53
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J Clin Oncol (2009) 3.38
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell (2007) 3.21
Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat Cell Biol (2008) 3.04
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest (2007) 3.01
Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA (1998) 3.00
Biochemical and kinetic characterization of the RNA helicase activity of eukaryotic initiation factor 4A. J Biol Chem (1999) 2.99
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell (2004) 2.91
Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem (2004) 2.87
The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol (2004) 2.78
Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J (1995) 2.78
Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress Chaperones (2002) 2.70
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol (2005) 2.70
Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J Biol Chem (2006) 2.67
4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications. Cancer Res (2007) 2.67
Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci U S A (1990) 2.66
Eukaryotic translation initiation factors and regulators. Curr Opin Struct Biol (2003) 2.63
The role of the 5' untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol (1999) 2.54
Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem (2001) 2.53
The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol (2010) 2.45
Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle (2009) 2.45
A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol Cell (2007) 2.44
Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J (2000) 2.40
Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc Natl Acad Sci U S A (2004) 2.32
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood (2009) 2.31
Effect on tumor cells of blocking survival response to glucose deprivation. J Natl Cancer Inst (2004) 2.30
The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell (2003) 2.28
GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res (2007) 2.26
Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur J Biochem (2002) 2.20
Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol Cell (2005) 2.17
Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell (2008) 2.17
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res (2006) 2.15
Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS One (2009) 2.11
Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res (2004) 2.06
The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene (1996) 2.04
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res (2009) 1.98
Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis (2003) 1.97
Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region. Proc Natl Acad Sci U S A (1985) 1.94
MicroRNAs in tumorigenesis: a primer. Am J Pathol (2007) 1.83
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood (2009) 1.83
Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem (2006) 1.80
RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation. Chem Biol (2006) 1.71
Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res (1997) 1.70
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem (2004) 1.69
Altering chemosensitivity by modulating translation elongation. PLoS One (2009) 1.68
4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clin Cancer Res (2007) 1.68
Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm (2009) 1.65
Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res (2004) 1.62
Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther (2004) 1.60
How do microRNAs regulate gene expression? Biochem Soc Trans (2008) 1.60
eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res (2009) 1.58
The relation of informational RNA to DNA. Cold Spring Harb Symp Quant Biol (1961) 1.56
Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation. Mol Cell Biol (2007) 1.54
Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry. Genes Dev (2005) 1.53
Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res (2000) 1.49
Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol (2006) 1.49
eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3'UTR. J Cell Biol (2005) 1.49
Uncoupling stress granule assembly and translation initiation inhibition. Mol Biol Cell (2009) 1.49
Selective pharmacological targeting of a DEAD box RNA helicase. PLoS One (2008) 1.49
Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. Am J Respir Cell Mol Biol (2007) 1.49
Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol (2008) 1.49
Binding of activated alpha2-macroglobulin to its cell surface receptor GRP78 in 1-LN prostate cancer cells regulates PAK-2-dependent activation of LIMK. J Biol Chem (2005) 1.45
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene (2000) 1.43
Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. Curr Opin Chem Biol (2010) 1.43
eIF4E: new family members, new binding partners, new roles. J Biol Chem (2009) 1.42
Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol (1999) 1.38
Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis. Prog Nucleic Acid Res Mol Biol (1993) 1.37
Untangling the unfolded protein response. Cell Cycle (2008) 1.32
Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Clin Cancer Res (2004) 1.31
Activation and clinical significance of the unfolded protein response in breast cancer. Br J Cancer (2009) 1.28
Cigarette smoke induces endoplasmic reticulum stress and the unfolded protein response in normal and malignant human lung cells. BMC Cancer (2008) 1.28
Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer (2010) 1.28
ERK and mTOR signaling couple beta-adrenergic receptors to translation initiation machinery to gate induction of protein synthesis-dependent long-term potentiation. J Biol Chem (2007) 1.27
Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res (2000) 1.26
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med (2013) 4.62
Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature (2012) 3.54
Translational regulation of gene expression during conditions of cell stress. Mol Cell (2010) 3.38
Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene (2004) 2.78
The implications of structured 5' untranslated regions on translation and disease. Semin Cell Dev Biol (2004) 2.78
The Apaf-1 internal ribosome entry segment attains the correct structural conformation for function via interactions with PTB and unr. Mol Cell (2003) 2.28
Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell (2008) 2.17
Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans (2008) 2.12
The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci U S A (2008) 2.09
Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo. Oncogene (2003) 1.83
p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci U S A (2010) 1.77
Polypyrimidine tract binding protein regulates IRES-mediated gene expression during apoptosis. Mol Cell (2006) 1.71
A perspective on mammalian upstream open reading frame function. Int J Biochem Cell Biol (2013) 1.59
Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes. Genes Dev (2009) 1.56
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood (2005) 1.56
Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry. Genes Dev (2005) 1.53
A novel method for poly(A) fractionation reveals a large population of mRNAs with a short poly(A) tail in mammalian cells. Nucleic Acids Res (2007) 1.45
Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol (2007) 1.44
Bag-1 internal ribosome entry segment activity is promoted by structural changes mediated by poly(rC) binding protein 1 and recruitment of polypyrimidine tract binding protein 1. Mol Cell Biol (2004) 1.38
Canonical initiation factor requirements of the Myc family of internal ribosome entry segments. Mol Cell Biol (2009) 1.21
Dysregulation of protein synthesis and disease. J Pathol (2010) 1.21
Polypyrimidine tract binding protein and poly r(C) binding protein 1 interact with the BAG-1 IRES and stimulate its activity in vitro and in vivo. Nucleic Acids Res (2003) 1.19
The involvement of microRNAs in Type 2 diabetes. Biochem Soc Trans (2010) 1.17
The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res (2010) 1.17
The role of IRES trans-acting factors in regulating translation initiation. Biochem Soc Trans (2010) 1.15
L-Myc protein synthesis is initiated by internal ribosome entry. RNA (2004) 1.03
Ribosomal protein S25 dependency reveals a common mechanism for diverse internal ribosome entry sites and ribosome shunting. Mol Cell Biol (2012) 0.99
The human insulin receptor mRNA contains a functional internal ribosome entry segment. Nucleic Acids Res (2009) 0.96
Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo. Mol Ther (2012) 0.90
Aberrant regulation of translation initiation in tumorigenesis. Curr Mol Med (2003) 0.90
Viral strategies to subvert the mammalian translation machinery. Prog Mol Biol Transl Sci (2009) 0.89
ATR (ataxia telangiectasia mutated- and Rad3-related kinase) is activated by mild hypothermia in mammalian cells and subsequently activates p53. Biochem J (2011) 0.88
Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site. Ann N Y Acad Sci (2007) 0.86
Rapamycin regulates biochemical metabolites. Cell Cycle (2013) 0.84
Evaluating bias-reducing protocols for RNA sequencing library preparation. BMC Genomics (2014) 0.83
eIF4A inhibition allows translational regulation of mRNAs encoding proteins involved in Alzheimer's disease. PLoS One (2010) 0.83
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab. Cell Cycle (2013) 0.83
Active regulator of SIRT1 is required for ribosome biogenesis and function. Nucleic Acids Res (2013) 0.82
Large scale integration of drug-target information reveals poly-pharmacological drug action mechanisms in tumor cell line growth inhibition assays. Oncotarget (2014) 0.79
Translation deregulation in B-cell lymphomas. Biochem Soc Trans (2010) 0.78
SF2/ASF TORCs up translation. Mol Cell (2008) 0.77
An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4. Integr Biol (Camb) (2011) 0.76
Co-ordinated regulation of translation following DNA damage. Cell Cycle (2009) 0.75